Eligibility Asthma NCT00746330

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00746330
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
5 to 11 years of age of either sex and of any race
Descrizione

age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
a diagnosis (according to the global initiative for asthma [gina] guidelines) of persistent asthma for a period of at least 6 months prior to screening and must have been on a stable asthma regimen (daily dose unchanged) for at least 4 weeks prior to screening
Descrizione

persistent asthma and stable asthma regimen

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3266628
UMLS CUI [1,2]
C0040223
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C0004096
UMLS CUI [2,3]
C0205360
UMLS CUI [2,4]
C0040223
β2-agonist reversibility, defined as an increase in absolute fev1 of ≥12% within 30 minutes after administration of 200μg of salbutamol without the use of a spacer or its equivalent in accordance with ats/ers standards
Descrizione

fev1 reversibility

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0748133
UMLS CUI [1,2]
C0449261
UMLS CUI [2]
C0001927
a child must have an fev1 of ≥ 60% and ≤ 90% of polgar predicted when all restricted medications have been withheld for the appropriate intervals
Descrizione

fev1

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0748133
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
use of other investigational drugs at the time of enrolment, or within 30 days or 5 half-lives of enrolment, whichever is longer.
Descrizione

investigational drugs

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0013230
UMLS CUI [1,2]
C0040223
history of malignancy of any organ system within past 5 years.
Descrizione

history of malignancy

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0040223
pre-dose change (increase or decrease) in absolute fev1 of 15% at visit 2, compared with value at screening.
Descrizione

pre-bronchodilator fev1

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3172227
hospitalized or had an emergency room treatment for an acute asthma exacerbation in the 1 month prior to visit 1, or who had a clinical deterioration of asthma between visits 1 and 2 that resulted in emergency treatment, hospitalization, or treatment with excluded asthma medication.
Descrizione

asthma exacerbation or deterioration with

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0349790
UMLS CUI [2]
C0019993
UMLS CUI [3]
C0583237
UMLS CUI [4,1]
C0868945
UMLS CUI [4,2]
C0004096
significant medication condition or situation.
Descrizione

significant medication condition or situation

Tipo di dati

boolean

qtc > 440 msec (boys) or > 450 msec (girls) on electrocardiogram(ecg) assessment at screening.
Descrizione

qtc

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0489625
upper or lower respiratory tract infection within 4 weeks prior to screening.
Descrizione

upper or lower respiratory tract infection

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0041912
UMLS CUI [2]
C0149725
UMLS CUI [3]
C0040223
chronic conditions affecting the respiratory tract or chronic lung diseases.
Descrizione

chronic conditions affecting the respiratory tract or chronic lung diseases

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0008679
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0035237
UMLS CUI [2]
C0746102

Similar models

Eligibility Asthma NCT00746330

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00746330
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
5 to 11 years of age of either sex and of any race
boolean
C0001779 (UMLS CUI [1])
persistent asthma and stable asthma regimen
Item
a diagnosis (according to the global initiative for asthma [gina] guidelines) of persistent asthma for a period of at least 6 months prior to screening and must have been on a stable asthma regimen (daily dose unchanged) for at least 4 weeks prior to screening
boolean
C3266628 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C0004096 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
C0040223 (UMLS CUI [2,4])
fev1 reversibility
Item
β2-agonist reversibility, defined as an increase in absolute fev1 of ≥12% within 30 minutes after administration of 200μg of salbutamol without the use of a spacer or its equivalent in accordance with ats/ers standards
boolean
C0748133 (UMLS CUI [1,1])
C0449261 (UMLS CUI [1,2])
C0001927 (UMLS CUI [2])
fev1
Item
a child must have an fev1 of ≥ 60% and ≤ 90% of polgar predicted when all restricted medications have been withheld for the appropriate intervals
boolean
C0748133 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
investigational drugs
Item
use of other investigational drugs at the time of enrolment, or within 30 days or 5 half-lives of enrolment, whichever is longer.
boolean
C0013230 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
history of malignancy
Item
history of malignancy of any organ system within past 5 years.
boolean
C0006826 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
pre-bronchodilator fev1
Item
pre-dose change (increase or decrease) in absolute fev1 of 15% at visit 2, compared with value at screening.
boolean
C3172227 (UMLS CUI [1])
asthma exacerbation or deterioration with
Item
hospitalized or had an emergency room treatment for an acute asthma exacerbation in the 1 month prior to visit 1, or who had a clinical deterioration of asthma between visits 1 and 2 that resulted in emergency treatment, hospitalization, or treatment with excluded asthma medication.
boolean
C0349790 (UMLS CUI [1])
C0019993 (UMLS CUI [2])
C0583237 (UMLS CUI [3])
C0868945 (UMLS CUI [4,1])
C0004096 (UMLS CUI [4,2])
significant medication condition or situation
Item
significant medication condition or situation.
boolean
qtc
Item
qtc > 440 msec (boys) or > 450 msec (girls) on electrocardiogram(ecg) assessment at screening.
boolean
C0489625 (UMLS CUI [1])
upper or lower respiratory tract infection
Item
upper or lower respiratory tract infection within 4 weeks prior to screening.
boolean
C0041912 (UMLS CUI [1])
C0149725 (UMLS CUI [2])
C0040223 (UMLS CUI [3])
chronic conditions affecting the respiratory tract or chronic lung diseases
Item
chronic conditions affecting the respiratory tract or chronic lung diseases.
boolean
C0008679 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0035237 (UMLS CUI [1,3])
C0746102 (UMLS CUI [2])